Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity

DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector
diagram bullet

Check conditions

DIABETES_FG

55191

diagram downward connector
diagram bullet

Filter registries

Operations: NOMESCO codes ^CKD65|^CKD05

2510

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

2510

diagram downward connector

Check minimum number of events None

2510

diagram downward connector

Include endpoints None

2510

diagram downward connector
DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 2449 1039 1410
Unadjusted prevalence (%) 0.79 0.60 1.04
Mean age at first event (years) 63.41 64.11 62.89

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 3.70 [2.43, 5.63] 1.0e-9 315
15 years 0.01 1.51 [1.00, 2.29] 5.2e-2 119
5 years 0.00 3.93 [2.88, 5.35] 3.8e-18 146
1 year 0.00 4.34 [2.88, 6.56] 3.0e-12 36

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: DM_EYE_OPER_REMOVAL_VITR_INJECT_DRUG – Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity
GWS hits:

Survival analyses between endpoints

Plot

before Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity
after Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Removal of vitreous via pars plana/pars plicata and injection of drug into the vitreous cavity